Previous Close | 0.3800 |
Open | 0.3900 |
Bid | 0.4000 x N/A |
Ask | 0.4150 x N/A |
Day's Range | 0.3900 - 0.4100 |
52 Week Range | 0.3450 - 0.6800 |
Volume | |
Avg. Volume | 53,864 |
Market Cap | 46.14M |
Beta (5Y Monthly) | 0.82 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1700 |
Earnings Date | Apr 25, 2024 - Apr 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.20 |
Nanalysis Scientific Corp. (TSXV: NSCI) (the "Company" or "Nanalysis") is pleased to announce that it has closed its prospectus exempt offering of units (the "Offering") and concurrent brokered "best efforts" prospectus exempt offering of units (the "Concurrent Offering"), as announced on March 6, 2024. A total of 11,111,110 units (the "Units") were issued at a price of $0.45 per Unit for gross proceeds of $4,999,999.50. A total of 8,888,888 Units were issued pursuant to the Offering and 2,222,2
Nanalysis Scientific Corp. (TSXV: NSCI) (the "Company" or "Nanalysis Scientific") is pleased to announce a best efforts prospectus exempt offering (the "Offering") of up to 11,111,111 units (the "Units") of the Company at a price of $0.45 per Unit (the "Issue Price") for gross proceeds of up to $5,000,000, pursuant to the listed issuer financing exemption available under Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106"). There is an offering document relating to the Off
Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference.